RALEIGH, N.C., Sept. 17, 2009 (GLOBE NEWSWIRE) -- On September 15, 2009, DARA BioSciences, Inc. (Nasdaq:DARA) received a notice from The NASDAQ Stock Market stating that the minimum bid price of the Company’s common stock was below $1.00 per share for 30 consecutive business days and that the Company was therefore not in compliance with Marketplace Rule 5550(a)(2). The notification letter has no effect at this time on the listing of the Company’s common stock on The NASDAQ Capital Market. DARA’s common stock will continue to trade on The NASDAQ Capital Market under the symbol DARA.
